Thursday, May 31, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Spectrum Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare ...
MarketWatch (press release)
HENDERSON, Nev., May 31, 2012 (BUSINESS WIRE) -- Spectrum Pharmaceuticals (nasdaqgs:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an ...
See all stories on this topic »
Catabasis Pharmaceuticals Appoints Henry Rath to Vice President, Business ...
MarketWatch (press release)
CAMBRIDGE, Mass., May 31, 2012 (BUSINESS WIRE) -- Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and ...
See all stories on this topic »
La Jolla Pharmaceutical Announces Issuance of US Patent Covering Modified ...
MarketWatch (press release)
SAN DIEGO, CA, May 31, 2012 (MARKETWIRE via COMTEX) -- La Jolla Pharmaceutical Company (otcqb:LJPC) (pinksheets:LJPC) (the "Company" and "La Jolla") announced today that the United States Patent and Trademark Office (USPTO) has issued patent number ...
See all stories on this topic »
Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of ...
MarketWatch (press release)
HORSHOLM, Denmark, May 31, 2012 /PRNewswire via COMTEX/ -- Veloxis Pharmaceuticals A/S (omx:VELO) today announced that a subgroup analysis of African-American stable kidney transplant patients enrolled in Study 3001, a Phase 3 non-inferiority study, ...
See all stories on this topic »
US FDA warns consumers & healthcare professionals about counterfeit version of ...
pharmabiz.com
The US Food and Drug Administration (FDA) has issued a warnings to consumers and healthcare professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet.
See all stories on this topic »
Biostar Pharmaceuticals, Inc. Provides Update Regarding Gel Capsule Safety Issues
Sacramento Bee
By Biostar Pharmaceuticals, Inc. XIANYANG, China, May 30, 2012 -- /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products ...
See all stories on this topic »
CSD reports continued growth in pharmaceutical marketing investments in Brazil ...
MarketWatch (press release)
Both Brazil and China showed marked increases in pharmaceutical marketing investments for 2011, despite a decline of more than 3% in worldwide investments. Brazil, one of the fastest-growing emerging markets, had total investments of US $4.4bn, ...
See all stories on this topic »
Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in ...
Sacramento Bee
By Taiho Pharmaceutical Co., Ltd. TOKYO, May 31, 2012 -- /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. announced on May 31 that a global Phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 will start in June this year.
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Wednesday, May 30, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
Sacramento Bee
By AcelRx Pharmaceuticals, Inc. REDWOOD CITY, Calif., May 30, 2012 -- /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the ...
See all stories on this topic »
Sun's key appointments lay the foundation for global growth
Hindu Business Line
Mr Israel Makov, former Chief Executive of Teva Pharmaceutical Industries, had just recently taken over as Chairman Bio-Light, they add. Whether Mr Shanghvi and Mr Makov knew each other earlier, or last year's deal brought them together – the alliance ...
See all stories on this topic »
Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global ...
MarketWatch (press release)
MALVERN, Pa., May 30, 2012 /PRNewswire via COMTEX/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) today announced that executive management will participate in the Goldman Sachs Global Healthcare Conference 2012 to be held June 5-7, 2012 at Terranea ...
See all stories on this topic »
BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing ...
MarketWatch (press release)
NOVATO, Calif., May 30, 2012 (GlobeNewswire via COMTEX) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that it has granted stock options, time-based restricted stock units and performance-based restricted stock units to Daniel Spiegelman ...
See all stories on this topic »
Valeant Pharmaceuticals To Syndicate Incremental Term Loans
MarketWatch (press release)
MONTREAL, May 30, 2012 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. today announced plans to syndicate $500 million of incremental term loans under its existing senior secured credit facilities to fund repayment of amounts ...
See all stories on this topic »
Indian Pharmaceutical Congress venue shifted to Chennai from Goa
pharmabiz.com
The 64th edition of the Indian Pharmaceutical Congress venue has been shifted from Goa to Chennai. The event will commence from December 6-9, 2012. The four-day event this year will be organized by the Association of Pharmacy Teachers of India (APTI).
See all stories on this topic »
Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data ...
MarketWatch (press release)
ROCKVILLE, Md., May 30, 2012 (BUSINESS WIRE) -- Rexahn Pharmaceuticals, Inc. (ASE:RNN) , a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a ...
See all stories on this topic »
NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference
EON: Enhanced Online News (press release)
BEDMINSTER, NJ--(EON: Enhanced Online News)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Jefferies 2012 Global Healthcare Conference in New York on Monday, June 4, 2012 at 11:30 am ET. The presentation will be available as a live ...
See all stories on this topic »
Taro boosts Sun Pharma Q4 net profit
Livemint
Taro Pharmaceutical almost doubled its sales and net profit Mumbai: Sun Pharmaceutical Industries Ltd, the country's most valuable drug maker, posted 85% growth in fourth quarter net profit thanks to the performance of its recently consolidated Israeli ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, May 29, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
US business, branded generics boost Sun Pharma Q4 numbers
Hindu Business Line
Sun Pharmaceutical Industries posted net sales of Rs 2330 crore for the three months ended March 31, a growth of 59 per cent over same quarter last year. The company registered a net profit of Rs 820 crore, equivalent to 35 per cent net margin, ...
See all stories on this topic »

Hindu Business Line
The Pharmaceutical Market: USA
MarketWatch (press release)
Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
See all stories on this topic »
Ranbaxy gets USFDA nod for acne drug
Hindu Business Line
Through a business agreement with the Canadian firm – Cipher Pharmaceuticals Inc – Ranbaxy Laboratories Inc (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Ltd, is expected to launch Absorica in the fourth quarter, the company said on Monday.
See all stories on this topic »
Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
MarketWatch (press release)
JERUSALEM, May 29, 2012 /PRNewswire via COMTEX/ -- Oramed Pharmaceuticals Inc. ( http://www.oramed.com ), a developer of oral drug delivery systems, announced today that it has received approval for a key patent by the New Zealand Patent Office.
See all stories on this topic »
Raptor Pharmaceutical Licenses Intellectual Property Related to Malaria From ...
MarketWatch (press release)
NOVATO, Calif., May 29, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , announced that the Company has acquired exclusive rights to intellectual property related to cysteamine and related ...
See all stories on this topic »
Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global ...
MarketWatch (press release)
PARSIPPANY, NJ, May 29, 2012 (BUSINESS WIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals, is scheduled to present at the Jefferies 2012 Global ...
See all stories on this topic »
The Pharmaceutical Market: India
Sacramento Bee
By Reportlinker Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in ...
See all stories on this topic »
Salix Pharmaceuticals to Present at Three Investment Conferences in June
MarketWatch (press release)
RALEIGH, NC, May 29, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three investment conferences during June 2012. Information regarding these conferences is provided below: Interested ...
See all stories on this topic »
The Pharmaceutical Market: Brazil
Sacramento Bee
By Reportlinker Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, May 28, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
/REPEAT -- Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN/
MarketWatch (press release)
Cipher Pharmaceuticals Inc. (TOR:CA:DND) announced today that the US Food and Drug Administration (FDA) has approved Absorica™, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant ...
See all stories on this topic »
Ranbaxy gets US OK for acne treatment
Reuters India
The product was jointly developed by Canadian group Cipher Pharmaceuticals (DND.TO) and Galephar Pharmaceutical Research, while Ranbaxy holds the US marketing rights. Post approval, Cipher will receive a $9 million milestone payment from Ranbaxy, ...
See all stories on this topic »
IDMA-APA Pharmaceutical Analysts' Convention on Sept 21 & 22 in Mumbai
pharmabiz.com
The Indian Drug Manufacturers' Association (IDMA) and Association of Pharmaceutical Analysts (APA) will be holding the 15th Pharmaceutical Analysts' Convention (PAC) on September 21 and 22, 2012 at Hotel Hyatt Regency, Mumbai.
See all stories on this topic »
Paladin Labs and Nuvo Research Sign Canadian License Agreement for Synera and ...
MarketWatch (press release)
MONTREAL, QUEBEC AND MISSISSAUGA, ONTARIO, May 28, 2012 (MARKETWIRE via COMTEX) -- May 28, 2012 - Paladin Labs Inc. (TOR:CA:PLB) , a leading specialty pharmaceutical company and Nuvo Research Inc. (TOR:CA:NRI) , a specialty pharmaceutical company ...
See all stories on this topic »
Nuvo Research and Paladin Labs Sign Canadian License Agreement for Synera and ...
MarketWatch (press release)
MISSISSAUGA, ON and MONTREAL, May 28, 2012 /PRNewswire via COMTEX/ -- Nuvo Research Inc. (TOR:CA:NRI) , a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune ...
See all stories on this topic »
UBS AG Sets Teva Pharmaceutical Industries Ltd Price Target at $52.00 (TEVA)
Daily Political
Research analysts at UBS AG (NYSE: UBS) cut their target price on shares of Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) from $60.00 to $52.00 in a report released on Friday. The firm currently has a "buy" rating on the stock.
See all stories on this topic »
Paladin Labs to market Nuvo Research's topical pain medication in Canada
Winnipeg Free Press
MONTREAL - Speciality pharmaceutical company Paladin Labs Inc. (TSX:PLB) announced Monday that it has been granted the exclusive right to market and sell a new pain medication developed by Nuvo Research Inc. (TSX:NRI). The medication, Synera, is a ...
See all stories on this topic »
Barclays Capital Reaffirms Equal Weight Rating on Teva Pharmaceutical ...
Daily Political
Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA)'s stock had its "equal weight" rating reaffirmed by Barclays Capital (NYSE: BCS) in a research note issued on Friday. A number of other firms have also recently commented on TEVA.
See all stories on this topic »
Needham & Company Gives Hold Rating to Teva Pharmaceutical Industries Ltd (TEVA)
Daily Political
Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA)'s stock had its "hold" rating restated by equities researchers at Needham & Company in a report issued on Friday. Shares of Teva Pharmaceutical Industries Ltd opened at 38.61 on Friday.
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Sunday, May 27, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
'National Pharma Pricing Policy may hurt industry in long-run'
Hindu Business Line
PTI Pharma analysts in India and abroad believe that cost-based pricing in National Pharmaceutical Pricing Policy is not suitable to safeguard the interests of patients as well as the pharma industry. The draft National Pharmaceutical Pricing policy, ...
See all stories on this topic »
Pharmaceutical firms demand transparent pricing mechanism
PakistanToday.com.pk
KARACHI - Pharma Bureau, a representative body of multinational pharmaceutical companies in Pakistan, has urged the government to implement a transparent and predictable pricing mechanism for the pharmaceutical industry enabling them to forecast future ...
See all stories on this topic »

PakistanToday.com.pk
Govt summons pharmaceutical company to 'fix price'
Pakistan Daily Times
ISLAMABAD: The government has summoned the representative of a pharmaceutical company on May 28 to explain the selling of anti-hepatitis injection for Rs 13000 on the basis of 'buy one get one free'. Unfortunately, poor patients are not benefiting from ...
See all stories on this topic »
Pharma firm asked to clarify pricing issue
Pakistan Observer
Islamabad—The Ministry of National Regulation and Services has summoned a multinational pharmaceutical company for a hearing on the price of injection of a medicine used for treatment of hepatitis in its upcoming price committee meeting on May 28.
See all stories on this topic »
'Off Label Use' Of Pharmaceuticals - A High Price For Medical Progress
Worldcrunch
Off label use is when doctors use treatment options that have not been officially approved for a particular malady, and are not on the list of pharmaceuticals insurance companies reimburse. Why would they do such a thing?
See all stories on this topic »

Worldcrunch
Interferon at discounted rate: Relief not reaching patients
DAWN.com
ISLAMABAD, May 26: The relief of a multinational pharmaceutical company, offering two free interferon injections to Hepatitis-C patients on the purchase of as many, seems not reaching the end users, it has been learnt.
See all stories on this topic »
Let's Stop Coddling Big Pharma Fraud
InjuryBoard.com
For America's pharmaceutical companies, committing fraud has become an established way of life. Practices like off-label marketing and price inflation are not only rampant, they bring in millions, sometimes billions of dollars in profit—more than ...
See all stories on this topic »
Greece 'running out of medication'
Sky News Australia
Many pharmacies now have huge debts to pharmaceutical companies for drugs they have handed out free of charge. Sky News spoke to one pharmacist who has not been paid by the state for over a year. Evaggelina Rousi, who runs a chemist in Athens, ...
See all stories on this topic »
Money and doctors: Private healthcare spending in Pakistan rises to $7.3 billion
The Express Tribune
Pharmaceuticals grew a little slower, at 13.1%, to reach Rs173 billion in gross sales in Pakistan. Pakistanis are increasingly spending more on health, with spending rising to a total of Rs665 billion in 2011, up 14.5% over the previous year, ...
See all stories on this topic »

The Express Tribune


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, May 26, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Takeda Pharma to acquire Brazilian-based Multilab for BRL 500 million
pharmabiz.com
Takeda Pharmaceutical Company Limited, a research-based global company, and Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. (Multilab), a leading Brazilian pharmaceutical company, jointly announced that both parties have signed an ...
See all stories on this topic »
KV Pharmaceutical Company States That Its Policy is Not to Comment on Unusual ...
MarketWatch (press release)
LOUIS, May 25, 2012 /PRNewswire via COMTEX/ -- KV Pharmaceutical Company (the "Company") today announced that in view of the unusual market activity in the Company's common stock, the NYSE has contacted the Company in accordance with its usual practice ...
See all stories on this topic »
Takeda Pharmaceutical Widens Global Footprint With $250M Multilab Acquisition
BioWorld Online
By Jennifer Boggs Only weeks after disclosing its goal of expanding into emerging markets in its 2012-2014 Mid-Range Plan, Takeda Pharmaceutical Co. Ltd. made a move in Brazil with the acquisition of Multilab Industria e Comercio de Produtos ...
See all stories on this topic »
Watson confirms Testim patent challenge
pharmabiz.com
Watson Laboratories, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market testosterone gel, 1%. Watson's 1% testosterone gel ...
See all stories on this topic »
SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee Bill
Sacramento Bee
By Society of Chemical Manufacturers and Affiliates WASHINGTON, May 25, 2012 /PRNewswire-USNewswire/ -- The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate ...
See all stories on this topic »
Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the ...
MarketWatch (press release)
COLORADO SPRINGS, Colo., May 25, 2012 (BUSINESS WIRE) -- Cannabis Science, Inc. (OBB:CBIS) , a pioneering US biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide insight on the upcoming release of its' new ...
See all stories on this topic »
Biology offers new options
Times of India
With new options in the pharmaceutical, food processing and agricultural industries, academics is no longer the only way forward for biological science graduates. "Biomedical engineering, bioinformatics, biometrics, biochemistry, microbiology, ...
See all stories on this topic »
Plant Bioscience grants Alnylam world-wide license to Baulcombe patent
pharmabiz.com
Leading RNAi therapeutics company, Alnylam Pharmaceuticals, Inc. and Plant Bioscience Limited (PBL), a technology development and intellectual property (IP) management company, have entered into a licensing agreement. PBL has granted Alnylam a ...
See all stories on this topic »
Mylan settles patent litigation relating to Sunovion's Brovana product
pharmabiz.com
Mylan Inc., a global pharmaceutical company committed to setting new standards in healthcare, announced that Mylan Specialty LP, f/k/a Dey Pharma, LP, has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Friday, May 25, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee Bill
MarketWatch (press release)
The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate for approving the Food and Drug Administration Safety and Innovation Act (S. 2516), bringing the nation ...
See all stories on this topic »
Takeda Pharmaceutical: To Acquire Brazil's Multilab Industria For BRL500M In Cash
Wall Street Journal
TOKYO (Dow Jones)--Takeda Pharmaceutical Co. (4502.TO) said Friday it will acquire Brazil's Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for BRL500 million ($246 million) in an all-cash deal, as it seeks to tap into emerging market ...
See all stories on this topic »
Pharmaceutical Preparations Manufacturing in the UK Industry Market Research ...
San Francisco Chronicle (press release)
The UK is the eighth-largest pharmaceutical market in the world. As such, the industry commands important positions in the local economy (with the overall pharmaceutical sector being the third-largest contributor to UK economic growth) and the global ...
See all stories on this topic »
Pharmaceutical Industry Labor Management Association (PILMA) Applauds Senate's ...
Sacramento Bee
By Pharmaceutical Industry Labor-Management Association WASHINGTON, May 24, 2012 -- /PRNewswire-USNewswire/ -- The member companies and unions of the Pharmaceutical Industry Labor Management Association (PILMA) applaud the Senate's 96 to 1 vote today ...
See all stories on this topic »
254 Pharmaceutical Firms Found To Produce Unsafe Gel Capsules In China
Bernama
BEIJING, May 25 (Bernama) -- China's food and drug watchdog announced on Friday that 254 pharmaceutical enterprises or 12.7 percent of all capsule makers in the country were found to be producing unsafe drug capsules during a month-long inspection ...
See all stories on this topic »
Sun Pharma's Israeli arm Taro doubles net profit
Livemint
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd's Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the ...
See all stories on this topic »
Takeda to Buy Multilab to Gain Sales Network in Brazil
Bloomberg
Takeda Pharmaceutical Co. (4502), Asia's largest drugmaker, agreed to buy closely held Multilab Industria e Comercio de Productos Farmaceuticos Ltda. for 500 million reais ($246 million) to gain a sales network in Brazil.
See all stories on this topic »
Simmons Named CEO of Pharmaceutical Product Development
Private Equity Hub (press release)
Wilmington, NC-based Pharmaceutical Product Development LLC has named David Simmons chairman and CEO. He joins from Pfizer Inc., where he served as president and general manager of the emerging markets and established products business units.
See all stories on this topic »
MIT's needleless injector draws interest from pharmaceutical companies.
Mass High Tech
By Lori Valigra An experimental MIT device that delivers a tiny, high-pressure jet of medicine through the skin without requiring a needle prick has already drawn the interest of pharmaceutical maker Sanofi and other large companies, according to one ...
See all stories on this topic »

Mass High Tech
Pharmaceuticals for flat duty on raw material import
Pakistan Observer
Islamabad—Leading multinational pharmaceutical companies have proposed a flat customs duty rate of 10 percent or below on the import of raw materials and pharmaceutical active ingredients subjected to higher rate of duty under the tariff ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost